Leeward Investments LLC MA Sells 17,196 Shares of The Allstate Co. (NYSE:ALL)

Leeward Investments LLC MA trimmed its stake in The Allstate Co. (NYSE:ALL) by 14.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 100,197 shares of the insurance provider’s stock after selling 17,196 shares during the period. Leeward Investments LLC MA’s holdings in Allstate were worth $19,317,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. State Street Corp lifted its stake in shares of Allstate by 1.1% in the 3rd quarter. State Street Corp now owns 11,496,306 shares of the insurance provider’s stock valued at $2,190,758,000 after purchasing an additional 126,922 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Allstate by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider’s stock valued at $1,178,164,000 after purchasing an additional 74,537 shares during the last quarter. Strategic Financial Concepts LLC lifted its stake in shares of Allstate by 15,062.3% in the 4th quarter. Strategic Financial Concepts LLC now owns 1,119,129 shares of the insurance provider’s stock valued at $215,757,000 after purchasing an additional 1,111,748 shares during the last quarter. Pathway Financial Advisers LLC lifted its stake in shares of Allstate by 18,472.5% in the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock valued at $199,642,000 after purchasing an additional 1,047,019 shares during the last quarter. Finally, FMR LLC lifted its stake in shares of Allstate by 11.8% during the 3rd quarter. FMR LLC now owns 933,352 shares of the insurance provider’s stock worth $177,010,000 after acquiring an additional 98,179 shares during the last quarter. 76.47% of the stock is owned by institutional investors.

Insider Activity

In other news, CFO Jesse E. Merten sold 40,102 shares of Allstate stock in a transaction on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the transaction, the chief financial officer now directly owns 18,115 shares in the company, valued at approximately $3,378,990.95. This trade represents a 68.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 1.80% of the company’s stock.

Allstate Trading Down 1.9 %

Shares of NYSE:ALL opened at $185.51 on Friday. The Allstate Co. has a 12-month low of $153.87 and a 12-month high of $209.88. The business’s fifty day simple moving average is $190.25 and its 200-day simple moving average is $190.29. The company has a market capitalization of $49.12 billion, a PE ratio of 10.92, a P/E/G ratio of 1.03 and a beta of 0.52. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. As a group, equities research analysts predict that The Allstate Co. will post 18.65 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on ALL shares. The Goldman Sachs Group raised their price target on Allstate from $209.00 to $230.00 and gave the stock a “buy” rating in a research note on Friday, November 15th. UBS Group raised their price target on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Wells Fargo & Company raised their price target on Allstate from $186.00 to $187.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 14th. Evercore ISI raised Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. Finally, Keefe, Bruyette & Woods raised their price target on Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 11th. One analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $217.94.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.